CLBAX
Price
$35.68
Change
-$0.04 (-0.11%)
Updated
Jun 5 closing price
Net Assets
243.73B
MTRBX
Price
$19.23
Change
-$0.04 (-0.21%)
Updated
Jun 5 closing price
Net Assets
7.55B
Interact to see
Advertisement

CLBAX vs MTRBX

Header iconCLBAX vs MTRBX Comparison
Open Charts CLBAX vs MTRBXBanner chart's image
American Funds American Balanced 529A
Price$35.68
Change-$0.04 (-0.11%)
VolumeN/A
Net Assets243.73B
MFS Total Return B
Price$19.23
Change-$0.04 (-0.21%)
VolumeN/A
Net Assets7.55B
CLBAX vs MTRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBAX vs. MTRBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Buy and MTRBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 244B vs. MTRBX (7.55B). CLBAX pays higher dividends than MTRBX: CLBAX (1.91) vs MTRBX (1.56). CLBAX was incepted earlier than MTRBX: CLBAX (23 years) vs MTRBX (32 years). MTRBX (1.47) is less costly to investors than CLBAX (0.58). MTRBX is a more actively managed with annual turnover of: 53.00 vs. CLBAX (44.00). CLBAX has a lower initial minimum investment than MTRBX: CLBAX (250) vs MTRBX (1000). CLBAX annual gain was more profitable for investors over the last year : 6.97 vs. MTRBX (-0.89). CLBAX return over 5 years is better than : 36.35 vs. MTRBX (4.03).
CLBAXMTRBXCLBAX / MTRBX
Total Expense Ratio0.581.4739%
Annual Report Gross Expense Ratio0.581.4739%
Fund Existence23 years32 years-
Gain YTD4.5862.164212%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets244B7.55B3,231%
Annual Yield % from dividends1.911.56122%
Returns for 1 year6.97-0.89-778%
Returns for 3 years24.302.84857%
Returns for 5 years36.354.03903%
Returns for 10 years71.7619.99359%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSICX28.25N/A
N/A
Goldman Sachs International Eq ESG C
HWLIX41.78N/A
N/A
Hotchkis & Wiley Large Cap Fdml Value I
VWNFX45.48N/A
N/A
Vanguard Windsor™ II Inv
SBHAX19.43N/A
N/A
Segall Bryant & Hamill All Cap Instl
FIKCX59.86N/A
N/A
Fidelity Advisor Health Care Z